26 Stocks Moving in Thursday’s Pre-Market Session
Gainers
Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday.
Evogen Granted Notice Of Allowance For U.S. Patent Titled ‘ISOLATED POLYNUCLEOTIDES AND POLYPEPTIDES, AND METHODS OF USING SAME FOR INCREASING NITROGEN USE EFFICIENCY OF PLANTS’
https://patentcenter.uspto.gov/#!/applications/16711563/ifw/docs
Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) announced its financial results for the fourth quarter and full year of 2021, ended December 31, 2021.
Recap: Evogene Q4 Earnings
Evogene (NASDAQ:EVGN) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Computational Biology Company Evogene Confirms Earnings Results Release Date
Computational biology company Evogene Ltd. (NASDAQ: EVGN) will release its financial results for the full year and fourth quarter of 2021 on March 10, 2022.
Evogene’s Canonic Ships First Batch Of Unique Cannabis Varieties To Europe
Medical grade cannabis products developer Canonic Ltd. and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), has shipped the first batch of its unique cannabis varieties to Portugal, following approval to export from the Israeli Ministry of Health and Ministry
Evogene Subsidiary Canonic Announce Results In Pre-Clinical Studies In Inflammatory And Pain Model Systems Conducted By Hadassah Medical Center And Migal – Galilee Research Institute
Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), announced today positive results in pre-clinical studies in
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Evogene’s Biomica Announces Clearance For First-In-Human Phase I Study Of BMC-128 In Combination With Bristol Myers Squibb’s Anti-PD-1 Opdivo
REHOVOT, Israel, Jan. 11, 2022 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE:
